These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8012939)

  • 1. Vinca alkaloids enhance the half-life of tumour ornithine decarboxylase.
    Morata P; Jiménez-Mesa J; Núñez de Castro I; Sánchez-Jiménez FM
    Cancer Lett; 1994 Jun; 81(2):209-13. PubMed ID: 8012939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axotomy-induced ornithine decarboxylase activity in the mouse dorsal root ganglion is inhibited by the vinca alkaloids.
    Soiefer AI; Moretto A; Spencer PS; Sabri MI
    Neurochem Res; 1988 Dec; 13(12):1169-73. PubMed ID: 2467222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: implications for translational regulation.
    Persson L; Oredsson SM; Anehus S; Heby O
    Biochem Biophys Res Commun; 1985 Aug; 131(1):239-45. PubMed ID: 3929778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine and serotonin inhibit induction of ornithine decarboxylase by ornithine in perifused Ehrlich ascites tumour cells.
    Matés JM; Sánchez-Jiménez FM; García-Caballero M; Núñez de Castro I
    FEBS Lett; 1989 Jul; 250(2):257-61. PubMed ID: 2753136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control by hyperthermia of ornithine decarboxylase in Ehrlich ascites tumor cells.
    Matsui-Yuasa I; Otani S; Morisawa S; Kageyama K; Onoyama Y
    Biochim Biophys Acta; 1989 Dec; 1014(3):225-8. PubMed ID: 2605255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation by 1,4-diamines of the ornithine decarboxylase activity induced by ornithine in perifused tumor cells.
    Matés JM; Sánchez-Jiménez F; López-Herrera J; Núñez de Castro I
    Biochem Pharmacol; 1991 Aug; 42(5):1045-52. PubMed ID: 1872891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamines and their biosynthetic enzymes in Ehrlich ascites-carcinoma cells. Modification of tumour polyamine pattern by diamines.
    Kallio A; Pösö H; Guha SK; Jänne J
    Biochem J; 1977 Jul; 166(1):89-94. PubMed ID: 901422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control by treatment with lithium chloride of ornithine decarboxylase in Ehrlich ascites tumor cells.
    Matsui-Yuasa I; Tsuruta D; Uemoto M; Hasuma T; Morisawa S; Otani S
    Biochem Pharmacol; 1991 Mar; 41(5):763-8. PubMed ID: 1847813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of S-adenosylmethionine decarboxylase by polyamines in Ehrlich ascites-carcinoma cells grown in culture.
    Alhonen-Hongisto L
    Biochem J; 1980 Sep; 190(3):747-54. PubMed ID: 6781485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difluoromethylornithine-induced amplification of ornithine decarboxylase genes in Ehrlich ascites carcinoma cells.
    Alhonen-Hongisto L; Kallio A; Sinervirta R; Seppänen P; Kontula KK; Jänne OA; Jänne J
    Biochem Biophys Res Commun; 1985 Jan; 126(2):734-40. PubMed ID: 2983688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIOCHEMICAL EFFECTS OF THE VINCA ALKALOIDS. II. A COMPARISON OF THE EFFECTS OF COLCHICINE, VINBLASTINE AND VINCRISTINE ON THE SYNTHESIS OF RIBONUCLEIC ACIDS IN EHRLICH ASCITES CARCINOMA CELLS.
    CREASEY WA; MARKIW ME
    Biochim Biophys Acta; 1964 Aug; 87():601-9. PubMed ID: 14220690
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acylated derivatives of ascorbate on ornithine decarboxylase induction in Ehrlich ascites tumor cells.
    Matsui-Yuasa I; Otani S; Morisawa S; Kageyama K; Onoyama Y; Yamazaki H; Miwa N
    Biochem Int; 1989 Mar; 18(3):623-9. PubMed ID: 2764967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehrlich ascites tumour cells become refractory to alpha-difluoromethylornithine at a certain stage of growth.
    Anehus S; Oredsson SM; Heby O
    Cell Biochem Funct; 1988 Apr; 6(2):115-21. PubMed ID: 3132336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumourigenicity, cell-surface glycoprotein changes and ornithine decarboxylase gene pattern in Ehrlich ascites-carcinoma cells.
    Alhonen-Hongisto L; Kallio A; Sinervirta R; Jänne OA; Gahmberg CG; Jänne J
    Biochem J; 1985 Aug; 229(3):711-5. PubMed ID: 2996487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of hepatic ornithine decarboxylase induction by the ornithine decarboxylase-inducing factor isolated from tumor ascites fluid: determination of target cells for the factor in the liver.
    Sasaki K; Imamura K; Tanaka T
    J Biochem; 1983 Sep; 94(3):949-59. PubMed ID: 6643430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of N-formylleurosine on DNA synthesis of Ehrlich ascites tumor.
    Pokorny E; Szikla K; Pályi I; Holczinger L
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1113-9. PubMed ID: 6684556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection.
    Ido M; Lagacé L; Chafouleas JG
    Cancer Res; 1990 Oct; 50(20):6554-8. PubMed ID: 2208115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays.
    Granzow C; Kopun M; Kröber T
    Cancer Res; 1995 Nov; 55(21):4837-43. PubMed ID: 7585517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ornithine decarboxylase activity in normal tissues of tumor-bearing mice during tumor growth.
    Noguchi T; Kashiwagi A; Tanaka T
    J Biochem; 1976 Feb; 79(2):451-4. PubMed ID: 1270412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.